comparemela.com

Latest Breaking News On - National health service miboko study - Page 1 : comparemela.com

Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update

Loughborough, England, Aug. 14, 2023 (GLOBE NEWSWIRE) Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today released its financial results for the quarter ended June 30, 2023 and provided a business update. Corporate Highlights: Previously announced initial patient data from UK NHS (National Health Servic

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.